Advancing Radiotherapy for Bladder Cancer: Randomised Phase II Trial of Adaptive Image-guided Standard or Dose-escalated Tumour Boost Radiotherapy (RAIDER)

S Hafeez¹, R Lewis², E Hall², R Huddart³; RAIDER Trial Management Group

Collaborators, Affiliations

Collaborators

RAIDER Trial Management Group:
A Birtle, A Choudhury, J Cresswell, F Foroudi, H Gribble, C Griffin, S Hafeez, E Hall, V H Hansen, A Henry, B Hindson, R Huddart, T Kron, P Kumar, R Lewis, D McLaren, H McNair, E Miles, A Mitra, A Moore, H Mostafid, A Omar, A Tolentino, M Varughese, C Vassallo-Bonner, K Warren-Oseni, A Webster, L Webster, P Wheeler

Affiliations

¹ Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK; Department of Radiotherapy, The Royal Marsden NHS Foundation Trust, London, UK. Electronic address: shaista.hafeez@icr.ac.uk.
² Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, UKS.
³ Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK; Department of Radiotherapy, The Royal Marsden NHS Foundation Trust, London, UK.

PMID: 33766502
DOI: 10.1016/j.clon.2021.02.012

Editorial

Advancing Radiotherapy for Bladder Cancer: Randomised Phase II Trial of Adaptive Image-guided Standard or Dose-escalated Tumour Boost Radiotherapy (RAIDER)

S Hafeez et al. Clin Oncol (R Coll Radiol). 2021 Jun.

. 2021 Jun;33(6):e251-e256.

doi: 10.1016/j.clon.2021.02.012. Epub 2021 Mar 23.

Authors

S Hafeez¹, R Lewis², E Hall², R Huddart³; RAIDER Trial Management Group

Collaborators

RAIDER Trial Management Group:
A Birtle, A Choudhury, J Cresswell, F Foroudi, H Gribble, C Griffin, S Hafeez, E Hall, V H Hansen, A Henry, B Hindson, R Huddart, T Kron, P Kumar, R Lewis, D McLaren, H McNair, E Miles, A Mitra, A Moore, H Mostafid, A Omar, A Tolentino, M Varughese, C Vassallo-Bonner, K Warren-Oseni, A Webster, L Webster, P Wheeler

Affiliations

¹ Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK; Department of Radiotherapy, The Royal Marsden NHS Foundation Trust, London, UK. Electronic address: shaista.hafeez@icr.ac.uk.
² Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, UKS.
³ Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK; Department of Radiotherapy, The Royal Marsden NHS Foundation Trust, London, UK.

PMID: 33766502
DOI: 10.1016/j.clon.2021.02.012

No abstract available

PubMed Disclaimer

Publication types

Actions
Actions

Associated data

Actions
- Search in PubMed
- Search in ClinicalTrials.gov

Grants and funding

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- scite Smart Citations
Medical
- ClinicalTrials.gov

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Advancing Radiotherapy for Bladder Cancer: Randomised Phase II Trial of Adaptive Image-guided Standard or Dose-escalated Tumour Boost Radiotherapy (RAIDER)

Collaborators

Affiliations

Advancing Radiotherapy for Bladder Cancer: Randomised Phase II Trial of Adaptive Image-guided Standard or Dose-escalated Tumour Boost Radiotherapy (RAIDER)

Authors

Collaborators

Affiliations

Publication types

Associated data

Grants and funding

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical